27th May 2022 | Pharma Updates
Torrent Pharma acquired four Dr. Reddy's brands
Torrent Pharmaceuticals, based in Ahmedabad, has agreed to acquire four of Dr. Reddy’s Laboratories’ brands, including Styptovit-E, Finast, Finast-T, and Dynapress.
Zydus Lifesciences received final FDA approval for chemotherapy medication Pemetrexed
Zydus Lifesciences announced that it has gained final permission from the US Food and Drug Administration to market Pemetrexed for injection, which is used to treat certain malignancies.
OSV FTWZ's breakthrough in pharmaceutical supply chain
OSV FTWZs and Logistics has evolved as one of India’s most creative supply chain organisations, proving to be a boon, particularly in the pharmaceuticals sector.
Novartis expects complete approval for Gleevec follow-up Scemblix
Novartis has received fast approval for Scemblix, a Gleevec follow-up medication, in previously treated chronic myeloid leukemia. With the addition of new clinical data, the business aims to convert it into a full nod.
Monkeypox PCR tests developed by Roche
Swiss multinational healthcare firm Roche said that it has created three PCR test kits alongside its subsidiary TIB Molbiol to assist scientists in tracking down the monkeypox virus.
Teva and Allergan secure $161.5 million opioid deal with West Virginia
Teva Pharmaceutical Industries TEVA and AbbVie’s Allergan business struck a $161.5 million deal to resolve charges that the firms caused an opioid epidemic in West Virginia.
Medical Marijuana establishes a pharma subsidiary in Brazil
Medical Marijuana, the first publicly traded cannabis firm in the United States, produced the world’s first cannabis-derived nutraceutical products, brands, and supply chain.
